Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vdyne
AddedFeb 15, 2024
UpdatedJun 18, 2026
Vdyne

Vdyne

Series C

Vdyne: A Minnesota-based medical organization innovating in tricuspid valve replacement and repair technology.

HQ
Maple Grove, MN, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Vdyne, founded in Maple Grove, Minnesota, is a privately held medical device company focused on developing innovative transcatheter valve technologies. Their core mission is to address the debilitating and life-threatening effects of tricuspid regurgitation through advanced medical devices. Vdyne's primary products include a tricuspid replacement valve and repair technology designed to enhance the function of a person's natural tricuspid valve, targeting a critical need in the cardiovascular market.

Notable affiliated individuals and investors have yet to be publicly detailed. However, Vdyne has achieved significant milestones in the development of its proprietary valve technology. The company's impact is marked by its commitment to improving patient outcomes for those suffering from tricuspid regurgitation, positioning itself as a key innovator in the medical device industry.

Vdyne - Similar Companies

Laplace Interventional logo

Laplace Interventional

laplaceint.com

VytronUS logo

VytronUS

Vascudyne logo

Vascudyne

TriFlo Cardiovascular logo

TriFlo Cardiovascular

triflocv.com

Neurodyne logo

Neurodyne

Vadovations logo

Vadovations

Viacor logo

Viacor

ValVention logo

ValVention

valvention.com

Ocudyne logo

Ocudyne

ocudyne.com

Dymicron logo

Dymicron

dymicron.com

WaveDyn Vision logo

WaveDyn Vision

Emboline logo

Emboline

Tau-Pnu Medical logo

Tau-Pnu Medical

InnoVein logo

InnoVein

Traverse Vascular logo

Traverse Vascular

Vdyne - Quick Facts

Who are Vdyne's competitors?

Companies similar to Vdyne include Laplace Interventional, VytronUS, Vascudyne and TriFlo Cardiovascular.

When was Vdyne founded?

Vdyne was founded in 2017.

Where is Vdyne's headquarters located?

Vdyne's headquarters is located in Maple Grove, MN, US.

When was Vdyne's last funding round?

Vdyne's most recent funding round was for $8M (USD) in December 2020.

How much has Vdyne raised to-date?

As of Dec 18, 2020, Vdyne has raised a total of $13.2M (USD).

How many employees does Vdyne have?

Vdyne has 6 employees as of Feb 5, 2024.

Vdyne - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research